Machine learning can help predict whether people newly diagnosed with MS will experience disability worsening that occurs ...

A study from Sweden’s Uppsala University discovered a link between microplastics and multiple sclerosis (MS). The research, published in the journal Environmental International, discovered that ...

Multiple sclerosis (MS) is a disorder that prompts the body's immune system to attack myelin, the protective sheath covering nerve cells in the brain, optic nerve and spinal cord. This can in turn ...

Sanofi SAN0.42%increase; green up pointing triangle shares fell after an experimental treatment for multiple sclerosis was hit by a double setback, with results of a late-stage study missing a key ...

The over-the-counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the brains of people with progressive forms of multiple sclerosis, according to new ...

TONIGHT IS THE FIRST PUBLIC PERFORMANCE BY A NEWLY FORMED CHOIR, COUPLING MEMBERS WITH ALL DIFFERENT MUSICAL ABILITIES WHO SHARE ONE COMMON THING. MULTIPLE SCLEROSIS. FROM PATIENTS TO CAREGIVERS, THIS ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The family of the company's co ...

Selma Blair is grateful to be feeling good. The Cruel Intentions star, who shared her multiple sclerosis (MS) diagnosis in 2018, offered a positive update on her health, revealing that she’s been ...

Selma Blair shared an update on her battle with multiple sclerosis (MS), more than seven years after revealing her diagnosis. Speaking to Stellar on Saturday, November 22, Blair, 53, confirmed she had ...

Serena Hostvet has trouble keeping her hand steady when drawing something simple like a pumpkin, and it infuriates her. “At this point, I would just give up,” said Hostvet, 43, of Eau Claire, ...

Many women with multiple sclerosis (MS) notice a worsening of symptoms or progression just as menopause begins. While getting older is linked with disease progression in both men and women, hormones ...

Roche said its fenebrutinib drug candidate met primary goals in two late-stage trials for multiple sclerosis, reducing attacks or delaying disability progression in two different forms of the disease.